China Regenerative Medicine International Limited (stock code: 08158) released its monthly return for the period ended 31 October 2025. The authorized share capital remained at 5,000,000,000 ordinary shares with a par value of HKD 0.20 per share, totaling HKD 1,000,000,000. The number of issued shares held steady at 304,252,480, with no treasury shares reported.

The announcement also indicated the existence of a new share option scheme under which 30,425,248 shares may potentially be issued, though no options were exercised and no new funds were raised during this period. No other movements—such as warrants, convertibles, or other share issuance agreements—were noted in the disclosure.